Premium
GH Research PLC (GHRS)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company’s lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating p... GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company’s lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and postpartum depression. It also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -4.04 | -16.2968939088 | 24.79 | 25.9399 | 19.74 | 307363 | 22.57197934 | CS |
| 4 | -0.48 | -2.26095148375 | 21.23 | 25.9399 | 19.74 | 267263 | 22.52539444 | CS |
| 12 | 5.5 | 36.0655737705 | 15.25 | 25.9399 | 12.77 | 234203 | 19.95683004 | CS |
| 26 | 6.12 | 41.8318523582 | 14.63 | 25.9399 | 12.04 | 299779 | 16.98897479 | CS |
| 52 | 8.12 | 64.2913697546 | 12.63 | 25.9399 | 11.32 | 296542 | 15.40939767 | CS |
| 156 | 7.9 | 61.4785992218 | 12.85 | 25.9399 | 5.05 | 191175 | 13.65878628 | CS |
| 260 | -1.25 | -5.68181818182 | 22 | 30.43 | 5.05 | 148588 | 14.24664764 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
